%0 Report
        %A Daysal, N. Meltem
%A Fredrickson, Camille
%A Kristiansen, Ida Lykke
%A Trandafir, Mircea
%A Zhang, Jonathan
        %T The Labor Market Impacts of GLP-1s
        %D 2026
        %8 2026 Jul
        %I Institute of Labor Economics (IZA)
        %C Bonn
        %7 IZA Discussion Paper
        %N 18787
        %U https://www.iza.org/publications/dp18787
        %X We estimate the causal impacts of GLP-1 treatment on labor market outcomes using linked Danish administrative data and a matched stacked difference-in-differences design. We compare patients who initiate GLP-1 treatment during the first two years of Semaglutide availability to observably similar patients who initiate four years later. We find that GLP-1 treatment reduces long-term sickness leave by 17.3%. We estimate total fiscal benefits of GLP-1 initiation of approximately 1.3–1.5% of annual labor income per employed individual. We do not detect statistically significant or economically meaningful impacts on income, labor force participation, or employment over four years.
        %K GLP-1
%K diabetes
%K obesity
%K fiscal spillover